DLBCL

Greg Nowakowski | ASCO 2018 | Gene expression profiling in ABC-type DLBCL patients: ROBUST phase III trial

L:

ASCO Annual Meeting, 1-5 June 2018, Chicago, IL

Grzegorz Nowakowski
Mayo Clinic, Rochester, US

Interview topic: Gene expression profiling in ABC-type DLBCL patients from the ROBUST phase III trial

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF